Insider filing · COR
Steven H Collis
Executive Chairman
profile →
Cencora, Inc.
COR · Healthcare · 49 filings in 24 months
ticker →
Steven H Collis sold $5.1M of Cencora (COR)
Executed Oct 22 2024, disclosed Oct 23 2024, 1 day later.
Value, as filed
$5.1M
21,509 sh × $235.80
Executed
Oct 22 2024
the trade date, as filed
Disclosed
Oct 23 2024
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SCSteven H Collis (Executive Chairman) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales), most often in Cencora, Inc. (COR). Across 2 priced purchase filings, the average 21-session return was -3.7% from execution and -3.5% from disclosure (delay-adjusted; derived). The largest single filing was $870K of ELV (3,000 sh × $289.84, as filed), executed Mar 5.
The name
CORHealthcare · Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Steven H Collis in COR
CORSALE
Cencora, Inc.
$9.1M31,350 sh × $289.86
Exec Sep 16 2025
Filed Sep 18 2025 · 5:30 PM ET CORSALE Cencora, Inc. $4.2M
14,579 sh × $289.98
Exec Aug 19 2025
Filed Aug 20 2025 · 5:30 PM ET CORSALE Cencora, Inc. $4.3M
14,578 sh × $292.67
Exec Jul 22 2025
Filed Jul 23 2025 · 5:30 PM ET CORSALE Cencora, Inc. $4.3M
14,579 sh × $292.62
Exec Jun 24 2025
Filed Jun 25 2025 · 5:30 PM ET CORSALE Cencora, Inc. $4.3M
14,578 sh × $293.84
Exec May 20 2025
Filed May 21 2025 · 5:30 PM ET CORSALE Cencora, Inc. $4.1M
14,579 sh × $281.81
Exec Apr 22 2025
Filed Apr 23 2025 · 5:30 PM ET CORSALE Cencora, Inc. $3.9M
14,578 sh across 2 lots
Exec Mar 25 2025
Filed Mar 26 2025 · 5:30 PM ET CORSALE Cencora, Inc. $3.7M
14,579 sh across 2 lots
Exec Feb 27 2025
Filed Feb 28 2025 · 5:30 PM ET